doi: 10.3109/10428194.2014.905774.
Epub 2014 May 6.
The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia
Affiliations
- PMID: 24650055
- DOI: 10.3109/10428194.2014.905774
Item in Clipboard
The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia
Leuk Lymphoma.
2014 Dec.
No abstract available
Similar articles
-
Generics in chronic myeloid leukemia: current arguments for and against and the established evidence.Expert Rev Hematol. 2014 Dec;7(6):697-9. doi: 10.1586/17474086.2014.966679. Epub 2014 Oct 8. Expert Rev Hematol. 2014. PMID: 25292262
-
Imatinib for chronic myeloid leukaemia: a NICE mess.Lancet. 2001 Dec 1;358(9296):1902. doi: 10.1016/S0140-6736(01)06901-X. Lancet. 2001. PMID: 11741655 No abstract available.
-
Targeted cancer therapy: from bench to bedside to patient.J Clin Oncol. 2014 Feb 1;32(4):268-70. doi: 10.1200/JCO.2013.53.8413. Epub 2013 Dec 23. J Clin Oncol. 2014. PMID: 24366939 No abstract available.
-
Pharmacoeconomic benefits of dasatinib in the treatment of imatinib-resistant patients with chronic myelogenous leukemia.Expert Rev Pharmacoecon Outcomes Res. 2009 Apr;9(2):117-21. doi: 10.1586/erp.09.1. Expert Rev Pharmacoecon Outcomes Res. 2009. PMID: 19402798 Review.
-
Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EU.Ann Hematol. 2015 Apr;94 Suppl 2(0 2):S249-57. doi: 10.1007/s00277-015-2319-x. Epub 2015 Mar 27. Ann Hematol. 2015. PMID: 25814091 Free PMC article. Review.
Cited by
-
Current evidence on the efficacy and safety of generic imatinib in CML and the impact of generics on health care costs.Blood Adv. 2021 Sep 14;5(17):3344-3353. doi: 10.1182/bloodadvances.2021004194. Blood Adv. 2021. PMID: 34477815 Free PMC article.
-
Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States.Cancer Med. 2019 Nov;8(15):6559-6565. doi: 10.1002/cam4.2545. Epub 2019 Sep 10. Cancer Med. 2019. PMID: 31502383 Free PMC article.
-
Comparative Clinical Outcomes and Safety of Generic Versus Original Imatinib in the Treatment of Chronic Myeloid Leukemia: A Real-World Cohort Study from Thailand.J Clin Med. 2025 May 25;14(11):3695. doi: 10.3390/jcm14113695. J Clin Med. 2025. PMID: 40507456 Free PMC article.
-
The tolerability issue of generic imatinib in patients with chronic myeloid leukemia (Comment on Adi J. Klil-Drori et al., Haematologica 2019;104(7):e293).Haematologica. 2019 Jul;104(7):e330. doi: 10.3324/haematol.2019.222000. Haematologica. 2019. PMID: 31257208 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
